DalsnaFinance

Pomdoctor $POM

Consumer Discretionary

China
Create a scorecard
$0.95
+0.09 (+10.47%)
As of Oct 5, 2026, 3:40 PM EDT · cached
Price history
Loading chart…

Pomdoctor (POM) is trading up at $0.95 (+10.47%), as of the latest quote. It operates in the Consumer Discretionary sector.

IPO: October 8, 2025 · $4.00 offering · NASDAQ · View IPO details →

Pomdoctor revenue & net income history (FY2023–FY2025)

RevenueNet income
CN¥399.9MCN¥93.7M−CN¥212.6MFY2023 revenue: CN¥304.9MFY2023 net income: −CN¥145.4M'23FY2024 revenue: CN¥342.6MFY2024 net income: −CN¥143.4M'24FY2025 revenue: CN¥399.9MFY2025 net income: −CN¥212.6M'25
Pomdoctor annual financial statements
FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
RevenueCN¥304.9MCN¥342.6MCN¥399.9M
Growth (year over year)—+12.4%+16.7%
Gross profitCN¥38.7MCN¥47.7MCN¥52.3M
Gross margin12.7%13.9%13.1%
Operating income−CN¥22.2M−CN¥25.8M−CN¥118.6M
Operating margin−7.3%−7.5%−29.7%
Net income−CN¥145.4M−CN¥143.4M−CN¥212.6M
Net margin−47.7%−41.9%−53.2%
EPS (diluted)−CN¥23.04−CN¥22.72−CN¥21.96
Balance sheet
Cash and equivalentsCN¥6.72MCN¥7.65MCN¥9.58M
Total assets—CN¥46.2MCN¥107.6M
Total liabilities—CN¥545.9MCN¥588.9M
Long-term debt——CN¥81.8M
Shareholders' equity−CN¥2.12B−CN¥2.26B−CN¥454.0M
Cash flow
Operating cash flow−CN¥45.8M−CN¥16.1M−CN¥148.5M
Capital expenditureCN¥111.9KCN¥37.8KCN¥1.01M
Free cash flow−CN¥45.9M−CN¥16.2M−CN¥149.5M

From Pomdoctor's 20-F filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Amounts are in Chinese Yuan (CNY), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →

About Pomdoctor

Headquarters
Guangzhou, China From SEC filings, Oct 2026

Recent News (3)

Other Consumer Discretionary companies to compare with POM

Browse all companies →